Live Breaking News & Updates on Mario Brkulj

Stay updated with breaking news from Mario brkulj. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Mendus AB: Mendus to present positive interim data from the ALISON trial in ovarian cancer at the AACR Annual Meeting 2023

Mendus AB: Mendus to present positive interim data from the ALISON trial in ovarian cancer at the AACR Annual Meeting 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Mario Brkulj , Erik Manting , Corey Davis , Clinical Research Excluding Trials , American Association For Cancer Research , Lifesci Advisors , Valency Communications , American Association , Cancer Research , Annual Meeting , Jeroen Rovers , Chief Medical Officer , High Grade Serous Ovarian Cancer , Immunomodulatory Agents , Nasdaq Stockholm , Sci Advisors ,

Mendus AB: Mendus secures second shareholder loan from Van Herk Investments and reduces the number of outstanding convertible bonds with Negma Group

07.03.2023 - Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that the Company has closed a second loan under the terms of the commitment from its largest shareholder Van Herk . ....

Mario Brkulj , Erik Manting , Corey Davis , Lotta Ferm , Lifesci Advisors , Negma Group , Valency Communications , Chief Financial Officer , Van Herk Investments , Abuse Regulation , Sci Advisors , Mendus Ab ,

Mendus AB: Change in number of shares and votes in Mendus AB (publ)

Mendus AB: Change in number of shares and votes in Mendus AB (publ)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mario Brkulj , Erik Manting , Corey Davis , Negma Group , Lifesci Advisors , Valency Communications , Wall Street , Swedish Financial Instruments Trading Act , Sci Advisors , Nasdaq Stockholm ,

Mendus AB: Live webcast to discuss clinical results of ADVANCE II trial presented at ASH 2022

07.12.2022 - Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, will host a live webcast to review the Company’s most recent clinical results of the ADVANCE II trial in AML maintenance, which . ....

Mario Brkulj , Erik Manting , Corey Davis , Lifesci Advisors , Valency Communications , Sci Advisors , Mendus Ab ,

Mendus AB: Mendus to participate in upcoming conferences in December 2022 and January 2023

05.12.2022 - Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the following upcoming investor and industry conferences: 64th Annual Society of . ....

United States , San Francisco , Mario Brkulj , Erik Manting , Corey Davis , Lifesci Advisors , Valency Communications , Business Development , Annual Society , Healthcare Meeting , Fight Cancer Day , Sci Advisors , Mendus Ab ,